Literature DB >> 7548224

Phosphorylation of eukaryotic elongation factor 2 in differentiating and proliferating HL-60 cells.

A Nilsson1, O Nygård.   

Abstract

Ca(2+)-and calmodulin-dependent protein kinase III (CaM PKIII) phosphorylates eukaryotic elongation factor 2 (eEF-2) in HL-60 cells. Dephosphorylation of the factor in these cells is catalyzed by phosphoprotein phosphatase 2A alone. Differentiation of the HL-60 cells by all-trans retinoic acid resulted in a reduced growth rate and a marked decrease in the intracellular concentration of eEF-2. During differentiation the activity of the eEF-2 kinase is gradually reduced and reaches 10% of that found in undifferentiated cells 5 days after the onset of differentiation. The capacity to dephosphorylate phospho-eEF-2 remained unaltered in the growth-arrested cells. Differentiation without reduced proliferation was induced in the HL-60 cells by interferon-gamma. Under these conditions, differentiation had no effect on the cellular content of eEF-2 or the ability to dephosphorylate phospho-eEF-2. However, the differentiated cells showed a dramatic decrease in the specific activity of the eEF-2 kinase. The results show that the cellular content of eEF-2 varies with the rate of proliferation and that the activity of the eEF-2 kinase is high in undifferentiated proliferating cells and decreases upon differentiation even under conditions of an unaltered growth rate.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7548224     DOI: 10.1016/0167-4889(95)00084-6

Source DB:  PubMed          Journal:  Biochim Biophys Acta        ISSN: 0006-3002


  3 in total

Review 1.  Subcellular localization of mRNA in neuronal cells. Contributions of high-resolution in situ hybridization techniques.

Authors:  M E Martone; J A Pollock; M H Ellisman
Journal:  Mol Neurobiol       Date:  1998-12       Impact factor: 5.590

2.  Ultrastructural localization of dendritic messenger RNA in adult rat hippocampus.

Authors:  M E Martone; J A Pollock; Y Z Jones; M H Ellisman
Journal:  J Neurosci       Date:  1996-12-01       Impact factor: 6.167

3.  Targeted silencing of elongation factor 2 kinase suppresses growth and sensitizes tumors to doxorubicin in an orthotopic model of breast cancer.

Authors:  Ibrahim Tekedereli; S Neslihan Alpay; Clint D J Tavares; Zehra E Cobanoglu; Tamer S Kaoud; Ibrahim Sahin; Anil K Sood; Gabriel Lopez-Berestein; Kevin N Dalby; Bulent Ozpolat
Journal:  PLoS One       Date:  2012-07-20       Impact factor: 3.240

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.